Immunology and Microbiology
Asthma
100%
Human Respiratory Syncytial Virus
63%
Immune Response
52%
Airway
49%
Viral Disease
47%
Respiratory Syncytial Virus Infection
45%
Virus
39%
T Cell
31%
Allergen
24%
Interferon Type I
24%
Bronchiolitis
23%
Macrophage
23%
Clinical Immunology
22%
Eosinophil
21%
Dupilumab
21%
Helminth
21%
Biological Product
20%
Asthma Exacerbation
20%
Microflora
19%
Allergic Airway Inflammation
19%
Dendritic Cell
19%
Peptides
18%
Immunotherapy
18%
Immunoglobulin E
17%
Cathelicidin
16%
Regulatory T Cell
14%
Immune Landscape
14%
Reslizumab
14%
Severe Asthma
14%
Adaptive Immune System
14%
Mediator
14%
Sensitization
13%
Cytokine
12%
Coinfection
10%
Atopic Dermatitis
10%
Immunology
10%
Influenza
9%
Hypersensitive Response
9%
Dynamics
9%
Multi-Omics
9%
Influenzavirus A
9%
Mouse Model
9%
Respiratory Virus
8%
Microorganism
8%
Omalizumab
8%
Innate Lymphoid Cell
8%
Cell Culture
8%
Alveolar Macrophage
8%
Respiratory Syncytial Virus
7%
Antiviral Activity
7%
Medicine and Dentistry
Asthma
97%
Diseases
54%
Lung
45%
Infection
33%
Human Respiratory Syncytial Virus
31%
Respiratory Disease
27%
Bronchiolitis
26%
Virus
22%
Clinical Immunology
22%
Allergic Rhinitis
21%
Systematic Review
21%
Dendritic Cell
21%
Pediatrics
19%
Pediatric Respiratory Medicine
16%
Influenza Vaccine
16%
Influenza Vaccination
16%
Cathelicidin
15%
Lymphoid Cell
15%
Antiviral Activity
15%
Primary Health Care
15%
Wheeze
14%
COVID-19
14%
Public Health Clinic
14%
Respiratory Tract Infection
14%
Silo-Filler's Disease
14%
Prostaglandin E2
14%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Immune Response
13%
Respiratory Syncytial Virus
12%
Respiratory Syncytial Virus Infection
12%
Allergen
10%
In Vitro
10%
Allergic Response
9%
Endotype
9%
Cross Sectional Study
8%
Disease Course
8%
Tamsulosin
8%
Lung Infection
8%
Cathelicidin Antimicrobial Peptide LL 37
8%
Biological Marker
8%
Host Resistance
8%
Biological Product
7%
Regulatory T Cell
7%
Immunology
7%
Atopic Dermatitis
7%
Macrophage
7%
Myeloid Cell
7%
Endoscopy
7%
Asthma in Adults
7%
Household
7%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
70%
Diseases
47%
Biological Product
29%
Dupilumab
23%
Omalizumab
17%
Antivirus Agent
16%
Atopic Dermatitis
15%
Allergic Airway Inflammation
15%
Inflammation
14%
Viral Respiratory Tract Infection
14%
microRNA
14%
Chronic Urticaria
14%
Allergic Reaction
14%
Virus Infection
14%
Infection
13%
Human Respiratory Syncytial Virus
12%
Bronchiolitis
11%
Allergen
9%
Immunotherapy
9%
Coronavirinae
9%
SARS Coronavirus
9%
Respiratory Tract Disease
8%
Microorganism
8%
Randomized Controlled Trial
8%
Antiviral Activity
8%
Disease Course
8%
Biological Marker
8%
Lung Infection
8%
Respiratory Virus
8%
Allergic Rhinitis
8%
Live Attenuated Influenza Vaccine
7%
Cystic Fibrosis
7%
Dispase
7%
Mitogen Activated Protein Kinase P38
7%
Morus
7%
Benralizumab
7%
Cathelicidin
7%
Non-Steroidal Anti-Inflammatory Drug
7%
Nose Polyp
7%
Mepolizumab
7%
Reslizumab
7%
Case-Control Study
7%
Icosanoid
7%
Nafamstat
7%
Nafamstat Mesilate
7%
Ovalbumin
5%